Garvan Institute of Medical Research-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2026

  1. Defective RNA Polymerase III sensing of mitochondrial DNA in pulmonary epithelial cells impairs type I IFN immunity to SARS-CoV-2

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 123, Núm. 12

2025

  1. A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity

    Journal of Experimental Medicine, Vol. 222, Núm. 2

  2. Deleterious variants in the autophagy-related gene RB1CC1/FIP200 impair immunity to SARS-CoV-2

    Nature Communications , Vol. 16, Núm. 1

2024

  1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

    Human Genetics and Genomics Advances, Vol. 5, Núm. 3

  2. SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency

    Journal of Experimental Medicine, Vol. 221, Núm. 9

2023

  1. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency

    Nature, Vol. 623, Núm. 7988, pp. 803-813

  2. Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia

    Journal of Experimental Medicine, Vol. 220, Núm. 5

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515